ChemicalBook > CAS DataBase List > Bavituximab

Bavituximab

Product Name
Bavituximab
CAS No.
648904-28-3
Chemical Name
Bavituximab
Synonyms
Tarvacin;BAVITUXIMAB;Anti-PS MAb 3G4;Research Grade Bavituximab;Research Grade Bavituximab (DGK10101)
CBNumber
CB51090946
Formula Weight
0
MOL File
Mol file
More
Less

Bavituximab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
ATB0010207
Product name
BAVITUXIMAB
Purity
98.00%
Packaging
5MG
Price
$495.07
Updated
2021/12/16
More
Less

Bavituximab Chemical Properties,Usage,Production

Uses

Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel.html" class="link-product" target="_blank">Paclitaxel (HY-B0015) and Carboplatin.html" class="link-product" target="_blank">Carboplatin (HY-17393), have enhanced inhibition on non-small-cell lung cancer[1].

in vivo

Sorafenib induces exposure of anionic phospholipids in tumor model in mice. Bavituximab (100 μg/mouse; i.v.; single dose; 48 h after Sorafenib treatment) traces phosphatidylserine exposure in vivo[2].

Animal Model:Mice bearing subcutaneous PLC/PRF/5, C3A, and Huh7 tumors[2]
Dosage:100 μg/mouse (Bavituximab/β2GP1)
Administration:Intravenous injection single dose; 48 h after sorafenib treatment (100 mg/kg; p.o.; single dose)
Result:Traced phosphatidylserine exposure in vivo in mice with tumors.

References

[1] Digumarti R, et al. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. DOI:10.1016/j.lungcan.2014.08.010
[2] Cheng X, et al. Antibody-Mediated Blockade of Phosphatidylserine Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinomas Xenografts. Ann Surg Oncol. 2016 Dec;23(Suppl 5):583-591. DOI:10.1245/s10434-016-5107-5

Bavituximab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Bavituximab Suppliers

LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
12952
Advantage
65
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58

648904-28-3, BavituximabRelated Search:


  • BAVITUXIMAB
  • Tarvacin
  • Research Grade Bavituximab (DGK10101)
  • Anti-PS MAb 3G4
  • Research Grade Bavituximab
  • 648904-28-3